skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:057928/0117   Pages: 54
Recorded: 10/27/2021
Attorney Dkt #:NO70169A
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 20
1
Patent #:
8338120
Issue Dt:
12/25/2012
Application #:
12039066
Filing Dt:
02/28/2008
Publication #:
US20090068699
Pub Dt:
03/12/2009
Title:
METHOD OF TREATING INFLAMMATION WITH GLUTAMINYL CYCLASE INHIBITORS
2
Patent #:
8058405
Issue Dt:
11/15/2011
Application #:
12500940
Filing Dt:
07/10/2009
Publication #:
US20100021478
Pub Dt:
01/28/2010
Title:
ANTIBODIES SPECIFIC FOR N-TERMINAL TRUNCATED AND PYROGLUTAMATE MODIFIED AMYLOID-BETA PEPTIDES
3
Patent #:
8518406
Issue Dt:
08/27/2013
Application #:
12544319
Filing Dt:
08/20/2009
Publication #:
US20100119478
Pub Dt:
05/13/2010
Title:
ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE)
4
Patent #:
8889709
Issue Dt:
11/18/2014
Application #:
12554584
Filing Dt:
09/04/2009
Publication #:
US20100125086
Pub Dt:
05/20/2010
Title:
USE OF ISOQC INHIBITORS IN THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES OR CONDITIONS
5
Patent #:
8962860
Issue Dt:
02/24/2015
Application #:
12554611
Filing Dt:
09/04/2009
Publication #:
US20100119475
Pub Dt:
05/13/2010
Title:
NOVEL INHIBITORS OF GLUTAMINYL CYCLASE
6
Patent #:
8486940
Issue Dt:
07/16/2013
Application #:
12880369
Filing Dt:
09/13/2010
Publication #:
US20110092501
Pub Dt:
04/21/2011
Title:
NOVEL INHIBITORS
7
Patent #:
9181233
Issue Dt:
11/10/2015
Application #:
13040159
Filing Dt:
03/03/2011
Publication #:
US20110224259
Pub Dt:
09/15/2011
Title:
INHIBITORS OF GLUTAMINYL CYCLASE
8
Patent #:
8269019
Issue Dt:
09/18/2012
Application #:
13044678
Filing Dt:
03/10/2011
Publication #:
US20110224254
Pub Dt:
09/15/2011
Title:
NOVEL INHIBITORS
9
Patent #:
8541596
Issue Dt:
09/24/2013
Application #:
13091276
Filing Dt:
04/21/2011
Publication #:
US20110262388
Pub Dt:
10/27/2011
Title:
NOVEL INHIBITORS
10
Patent #:
9156907
Issue Dt:
10/13/2015
Application #:
13252929
Filing Dt:
10/04/2011
Publication #:
US20120064547
Pub Dt:
03/15/2012
Title:
DIAGNOSTIC ANTIBODY ASSAY
11
Patent #:
8809508
Issue Dt:
08/19/2014
Application #:
13422583
Filing Dt:
03/16/2012
Publication #:
US20120237529
Pub Dt:
09/20/2012
Title:
DIAGNOSTIC ANTIBODY ASSAY
12
Patent #:
8530670
Issue Dt:
09/10/2013
Application #:
13422619
Filing Dt:
03/16/2012
Publication #:
US20120237475
Pub Dt:
09/20/2012
Title:
NOVEL INHIBITORS
13
Patent #:
8420828
Issue Dt:
04/16/2013
Application #:
13547501
Filing Dt:
07/12/2012
Publication #:
US20120283259
Pub Dt:
11/08/2012
Title:
NOVEL INHIBITORS
14
Patent #:
9173885
Issue Dt:
11/03/2015
Application #:
13910702
Filing Dt:
06/05/2013
Publication #:
US20140065095
Pub Dt:
03/06/2014
Title:
NOVEL INHIBITORS
15
Patent #:
9157918
Issue Dt:
10/13/2015
Application #:
13948363
Filing Dt:
07/23/2013
Publication #:
US20130302835
Pub Dt:
11/14/2013
Title:
ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1PE)
16
Patent #:
9657089
Issue Dt:
05/23/2017
Application #:
14280919
Filing Dt:
05/19/2014
Publication #:
US20140255414
Pub Dt:
09/11/2014
Title:
DIAGNOSTIC ANTIBODY ASSAY
17
Patent #:
9512115
Issue Dt:
12/06/2016
Application #:
14775785
Filing Dt:
09/14/2015
Publication #:
US20160031869
Pub Dt:
02/04/2016
Title:
NOVEL INHIBITORS
18
Patent #:
9676843
Issue Dt:
06/13/2017
Application #:
14844726
Filing Dt:
09/03/2015
Publication #:
US20160053001
Pub Dt:
02/25/2016
Title:
Uses of Antibodies Directed Against Amyloid-beta
19
Patent #:
9650362
Issue Dt:
05/16/2017
Application #:
14862245
Filing Dt:
09/23/2015
Publication #:
US20160039795
Pub Dt:
02/11/2016
Title:
NOVEL INHIBITORS
20
Patent #:
10603367
Issue Dt:
Application #:
15866773
Filing Dt:
01/10/2018
Publication #:
US20180140689
Pub Dt:
05/24/2018
Title:
HUMANIZED ANTIBODIES
Assignor
1
PROBIODRUG AG
Exec Dt:
05/31/2021
Assignee
1
VIVORYON THERAPEUTICS AG
WEINBERGWEG 22
HALLE (SAALE), GERMANY 06120
Correspondence name and address
CANTOR COLBURN LLP
20 CHURCH STREET, 22ND FLOOR
HARTFORD, CT 06103

Search Results as of: 08/30/2025 04:36 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT